| NAFLD | Non-alcoholic fatty liver disease |
| CON | Control |
| HFF | High-fructose high-fat |
| NASH | Non-alcoholic steatohepatitis |
| M | Male |
| F | Female |
| BW | Body weight |
| CON-N | Control |
| ME | Metabolizable energy |
| CON-P | Control with probiotics |
| HFF-N | High-fructose high-fat |
| HFF-P | High-fructose high-fat with probiotics |
| BCA | Bicinchoninic acid |
| TNFα | Tumor necrosis factor alpha |
| IL-1α | Interleukin 1 alpha |
| PKB | Protein kinase B |
| LC3 | Microtubule-associated protein light chain 3 |
| p62 | Ubiquitin-binding protein |
| RT | Room temperature |
| TBST | Tris-buffered saline with tween |
| UPLC | Ultra-performance liquid chromatography |
| PBS | Phosphate-buffered saline |
| ORO | Oil red O |
| AF | Alexa Fluor |
| TAG | Triacylglycerol |
| SE | Standard error |
| PCA | Principal component analysis |
| IMCL | Intramyocellular lipid |
| EMCL | Extramyocellular lipid |
| CPT1 | Carnitine palmitoyltransferase I |
| PGC1α | Peroxisome proliferator-activated receptor gamma coactivator 1 alpha |
| GLUT4 | Glucose transporter type 4 |
| TOP2B | DNA topoisomerase 2β |